Laura Koeth

2.2k total citations · 1 hit paper
35 papers, 1.1k citations indexed

About

Laura Koeth is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Laura Koeth has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 15 papers in Epidemiology and 14 papers in Infectious Diseases. Recurrent topics in Laura Koeth's work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Antibiotic Resistance in Bacteria (14 papers) and Antimicrobial Resistance in Staphylococcus (14 papers). Laura Koeth is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (23 papers), Antibiotic Resistance in Bacteria (14 papers) and Antimicrobial Resistance in Staphylococcus (14 papers). Laura Koeth collaborates with scholars based in United States, United Kingdom and Italy. Laura Koeth's co-authors include Jane E. Ambler, Tanis C. Dingle, Romney M. Humphries, Dwight J. Hardy, Barbara Zimmer, Susan M. Butler‐Wu, Janet A. Hindler, Stephanie L. Mitchell, Mariana Castanheira and Jennifer Dien Bard and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Laura Koeth

34 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests

2018 519 citations Romney M. Humphries, Jane E. Ambler et al. Journal of Clinical Microbiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Koeth United States	12	380	336	292	254	250	35	1.1k
Deborah Ashcraft United States	16	379 1.0×	364 1.1×	292 1.0×	223 0.9×	149 0.6×	30	915
Jui‐Fen Lai Taiwan	19	310 0.8×	406 1.2×	189 0.6×	277 1.1×	213 0.9×	28	920
Matthias Marschal Germany	16	270 0.7×	323 1.0×	291 1.0×	294 1.2×	529 2.1×	31	1.4k
Chris M. Pillar United States	23	623 1.6×	573 1.7×	291 1.0×	287 1.1×	341 1.4×	45	1.4k
An-Jing Kuo Taiwan	21	278 0.7×	499 1.5×	293 1.0×	389 1.5×	220 0.9×	33	1.1k
M. Leticia McElmeel United States	12	511 1.3×	231 0.7×	360 1.2×	248 1.0×	250 1.0×	23	896
Adam Belley United States	17	466 1.2×	344 1.0×	156 0.5×	167 0.7×	264 1.1×	32	928
Klaudia Kosowska-Shick United States	19	708 1.9×	320 1.0×	262 0.9×	278 1.1×	380 1.5×	35	1.1k
Diego Faccone Argentina	20	222 0.6×	624 1.9×	173 0.6×	215 0.8×	246 1.0×	64	1.1k
Jane E. Ambler United States	12	283 0.7×	533 1.6×	160 0.5×	440 1.7×	308 1.2×	24	1.2k

Countries citing papers authored by Laura Koeth

Since Specialization

Citations

This map shows the geographic impact of Laura Koeth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Koeth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Koeth more than expected).

Fields of papers citing papers by Laura Koeth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Koeth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Koeth. The network helps show where Laura Koeth may publish in the future.

Co-authorship network of co-authors of Laura Koeth

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Koeth. A scholar is included among the top collaborators of Laura Koeth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Koeth. Laura Koeth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Koeth, Laura, et al.. (2024). A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution. Journal of Clinical Microbiology. 63(2). e0092624–e0092624. 1 indexed citations

2.

Koeth, Laura, et al.. (2023). Analysis of the effect of urine on the in vitro activity of gepotidacin and levofloxacin against Escherichia coli, Staphylococcus epidermidis, and Staphylococcus saprophyticus. Diagnostic Microbiology and Infectious Disease. 106(3). 115946–115946. 2 indexed citations

3.

Scangarella-Oman, Nicole E., et al.. (2021). Analysis of antimicrobial susceptibility testing methods and variables and in vitro activity of gepotidacin against urogenital Neisseria gonorrhoeae in men. Diagnostic Microbiology and Infectious Disease. 101(4). 115484–115484. 5 indexed citations

4.

Humphries, Romney M., Jane E. Ambler, Stephanie L. Mitchell, et al.. (2018). CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests. Journal of Clinical Microbiology. 56(4). 519 indexed citations breakdown →

5.

Koeth, Laura, Erika Matuschek, Gunnar Kahlmeter, & Gregory G. Stone. (2018). Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg. European Journal of Clinical Microbiology & Infectious Diseases. 37(6). 1047–1053. 5 indexed citations

6.

Koeth, Laura, Petra Apfalter, Karsten Becker, et al.. (2016). Multi-center and multi-method evaluation of in vitro activities of ceftaroline against S. aureus. Diagnostic Microbiology and Infectious Disease. 85(4). 452–458. 4 indexed citations

7.

Hastey, Christine J., Audrey N. Schuetz, Karen Anderson, et al.. (2016). Changes in the antibiotic susceptibility of anaerobic bacteria from 2007–2009 to 2010–2012 based on the CLSI methodology. Anaerobe. 42. 27–30. 39 indexed citations

8.

Mortensen, Joel E., et al.. (2016). Characterisation of carbapenem-resistant Enterobacteriaceae from the southwestern Ohio, northern Kentucky and southeastern Indiana region. Journal of Global Antimicrobial Resistance. 7. 141–144. 4 indexed citations

9.

Koeth, Laura, et al.. (2015). A Reference Broth Microdilution Method for Dalbavancin <em>In Vitro</em> Susceptibility Testing of Bacteria that Grow Aerobically. Journal of Visualized Experiments. 24 indexed citations

10.

Koeth, Laura, et al.. (2015). A Reference Broth Microdilution Method for Dalbavancin <em>In Vitro</em> Susceptibility Testing of Bacteria that Grow Aerobically. Journal of Visualized Experiments. 4 indexed citations

11.

Koeth, Laura, Erika Matuschek, Gunnar Kahlmeter, Richard A. Alm, & Jane E. Ambler. (2014). Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk. European Journal of Clinical Microbiology & Infectious Diseases. 33(9). 1511–1517. 5 indexed citations

12.

Koeth, Laura, et al.. (2010). Comparison of daptomycin Etest MICs on Mueller Hinton, IsoSensitest and brain heart infusion agars from Europe against 20 Staphylococcus aureus isolates. European Journal of Clinical Microbiology & Infectious Diseases. 29(10). 1261–1264. 7 indexed citations

13.

Koeth, Laura. (2008). Comparison of Daptomycin Etest MICs on European Mueller Hinton and IsoSensitest Agars Against 20 Staphylococcus aureus. 46th Annual Meeting. 2 indexed citations

14.

Sader, Hélio S., Laura Koeth, James A. Poupard, & Ronald N. Jones. (2008). Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agent. Diagnostic Microbiology and Infectious Disease. 62(4). 460–463. 3 indexed citations

15.

Koeth, Laura & Linda A. Miller. (2005). Evolving Concepts of Pharmaceutical Company–Sponsored Surveillance Studies. Clinical Infectious Diseases. 41(s4). S279–S282. 3 indexed citations

16.

Koeth, Laura, et al.. (2004). Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin. International Journal of Antimicrobial Agents. 24(2). 144–149. 8 indexed citations

17.

Koeth, Laura, Michael R. Jacobs, Caryn E. Good, et al.. (2004). Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000. International Journal of Infectious Diseases. 8(6). 362–373. 6 indexed citations

18.

Koeth, Laura, D. Felmingham, Michael R. Jacobs, & Flávia Rossi. (2004). Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000. International Journal of Antimicrobial Agents. 23(4). 356–361. 14 indexed citations

19.

Koeth, Laura, et al.. (2002). Comparative in vitro activity of gemifloxacin to other fluoroquinolones and non-quinolone agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1999–2000. International Journal of Antimicrobial Agents. 19(1). 33–37. 10 indexed citations

20.

Koeth, Laura. (2000). Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method. Journal of Antimicrobial Chemotherapy. 46(3). 369–376. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact